« Back
Home /
Erlotinib hydrochloride

Erlotinib hydrochloride

Item no.	TMO-T0373L-200mg
Manufacturer	TargetMol
CASRN	183319-69-9
Amount	200 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 g 1 mL 200 mg 500 mg 50 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,9952
Citations	1. Moyer JD, et al. Y Res. 1997, 57(21), 4838-4848.
Smiles	Cl.COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	OSI-744,NSC 718781,Erlotinib HCl,CP-358774
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Autophagy\|\|\|EGFR
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	429.9
Description	Erlotinib hydrochloride (NSC 718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.
Pathways	Autophagy\|\|\|Angiogenesis\|\|\|JAK/STAT signaling\|\|\|Tyrosine Kinase/Adaptors
Bioactivity	Erlotinib is a direct acting inhibitor against human EGFR tyrosine kinase (IC50: 2 nM). Erlotinib hydrochloride (trade name Tarceva) is a drug used in the treatment of pancreatic Y, non-small cell lung Y and some other types of Y.
Receptor	EGFR/HER1

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T0373L-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question